Clinical Trial Update: Study is Designed to Assess the Safety and Tolerability of AZD4547 at Increasing Doses in Patients With Advanced Tumours [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating safety and tolerability of AZD4547 at increasing doses in patients with advanced solid tumors was terminated; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Solid Tumors

Drugs mentioned

• AZD4547

Snippet

Sponsor: AstraZeneca | Conditions: Cancer, Advanced Solid Malignancies | Phase 1 | Status: TERMINATED | Results posted: 2019-03-15